| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/23/2005 | WO2005007814A3 Genome mapping of functional dna elements and cellular proteins |
| 06/23/2005 | WO2005007808A3 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 06/23/2005 | WO2005006958A8 Modulation of ceacam1 expression |
| 06/23/2005 | WO2005004592A9 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 06/23/2005 | WO2005000901A3 Cd20-specific antibodies and methods of employing same |
| 06/23/2005 | WO2004096142A3 Alk protein tyrosine kinase, cells and methods embodying and using same |
| 06/23/2005 | WO2004090153A3 Polymerase inhibitor and method of using same |
| 06/23/2005 | WO2004074498A3 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 06/23/2005 | WO2004074462A3 Delta-endotoxin genes and methods for their use |
| 06/23/2005 | WO2003106639A8 Recombination of nucleic acid library members |
| 06/23/2005 | WO2003102163A8 Methods of diagnosing and treating diabetes and insulin resistance |
| 06/23/2005 | US20050138694 Ultra-fast transformation technique for monocotyledons |
| 06/23/2005 | US20050138693 Generating transgenic plant; incubate tissue in low-oxygen environment, transform cells via agrobacterium, regenerate plants; tissue engineering |
| 06/23/2005 | US20050138692 Production of cancer-specific antibodies in plants |
| 06/23/2005 | US20050138691 Nucleotide sequences plant transport protein for use as tool in identifying modulators of plant growth; herbicide resistance |
| 06/23/2005 | US20050138690 Expression vector comprising exogenous regulatory and gene sequences for use in generation of plants with tissue specific expression of heterologous gene product; improving exogenous gene expression |
| 06/23/2005 | US20050138689 Expression vector coding short interfering RNA sequences for use as tool in controlling gene expression in plants; gene expression inhibition; target sequence suppression and target sequence validation |
| 06/23/2005 | US20050138688 Starch Hydrolytic Enzyme; similar, in general terms, to previously known alpha-amylases since both activities are able to hydrolyze starch, amylopectin, amylose, and beta-limit dextrin but are not able to hydrolyze the branched polymer pullulan |
| 06/23/2005 | US20050138687 Using viral cell-to-cell transfer as screening and diagnostic tool in identifying triple gene block 3 mutants; generating disease resistant plants |
| 06/23/2005 | US20050138686 Alternative splicing factors polynucleotides polypeptides and uses thereof |
| 06/23/2005 | US20050138685 Bacillus Cry9 family members |
| 06/23/2005 | US20050138680 Method for generating non-human mammalian chimeric embryo |
| 06/23/2005 | US20050138679 Method of evaluating useful cattle |
| 06/23/2005 | US20050138678 Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expression |
| 06/23/2005 | US20050138677 Transgenic animal model for the treatment of skin tumors |
| 06/23/2005 | US20050138676 Identification of genes involved in Alzheimer's disease using Drosophila melanogaster |
| 06/23/2005 | US20050137388 Real-time nucleic acid detection processes and compositions |
| 06/23/2005 | US20050137386 Expression vector comprising nucleotide sequences coding citrate synthase and malate dehydrogenase for use in generating plants resistant presence aluminum in soils; pollution control |
| 06/23/2005 | US20050137384 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/23/2005 | US20050137160 Antisense modulation of cholesteryl ester transfer protein expression |
| 06/23/2005 | US20050137158 Methods for targeting RNA molecules |
| 06/23/2005 | US20050137155 RNA interference mediated treatment of Parkinson disease using short interfering nucleic acid (siNA) |
| 06/23/2005 | US20050137153 RNA interference mediated inhibition of alpha-1 antitrypsin (AAT) gene expression using short interfering nucleic acid (siNA) |
| 06/23/2005 | US20050137151 si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation |
| 06/23/2005 | US20050137137 Inhibitors of the Interaction between p53 and MDM2 |
| 06/23/2005 | US20050137131 UspA1 and UspA2 antigens of Moraxella catarrhalis |
| 06/23/2005 | US20050137112 determining lymphocyte epitopes in proteins comprising obtaining from blood, a solution of dendritic cells and CD4 antigens, then promoting cell differentiation, by exposing to cytokines, then mixing with peptides of interest and measuring the proliferation of lymphocytes |
| 06/23/2005 | US20050137111 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 06/23/2005 | US20050136685 Chips, and apparatus and method for reaction analysis |
| 06/23/2005 | US20050136539 Generating immortalized human renal proximal tubule epithelial cell (RPTEC) for use as model for identifying modulators of renal toxicity |
| 06/23/2005 | US20050136525 Expression of granular starch hydrolyzing enzymes in Trichoderma and process for producing glucose from granular starch substrates |
| 06/23/2005 | US20050136524 Non-maltogenic exoamylase for use in improving quality of dough and baked goods |
| 06/23/2005 | US20050136519 Production of polyunsaturated fatty acids in oleaginous yeasts |
| 06/23/2005 | US20050136515 Nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 06/23/2005 | US20050136514 Related to sodium/glucose cotransporter subfamily; drug screening; biochips; host cells |
| 06/23/2005 | US20050136512 Modified g-protein for use in identifying modulators for enhancement of taste and smell; screening ligand binding activity |
| 06/23/2005 | US20050136511 GABA B receptors |
| 06/23/2005 | US20050136493 Using immunoglobulin to detect alpha -methylacyl-CoA racemase (AMACR) in urine; immunodiagnostic and cell proliferative disorders |
| 06/23/2005 | US20050136491 Method of site specific labeling of proteins and uses therefor |
| 06/23/2005 | US20050136484 Method for screening agents for the treatment of diabetes |
| 06/23/2005 | US20050136476 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 06/23/2005 | US20050136475 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/23/2005 | US20050136474 Truncation SELEX method |
| 06/23/2005 | US20050136470 Apparatus for detecting biopolymers and cartridge |
| 06/23/2005 | US20050136467 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders |
| 06/23/2005 | US20050136465 Screening assays |
| 06/23/2005 | US20050136463 Recovering preferential nucleotide sequences from salt solution using alumina binding and centrifugation; solid phase extraction |
| 06/23/2005 | US20050136462 Method for engineering nicking enzymes |
| 06/23/2005 | US20050136460 Using expression pattern of multiple antibiotic resistance gene as an evaluative tool for monitoring efficacy of microbiocides |
| 06/23/2005 | US20050136459 Double adhesive covering comprised of hydrophobic material for use as sealing component in bipolymer array reaction chamber |
| 06/23/2005 | US20050136458 Method for nucleic acid preparation |
| 06/23/2005 | US20050136456 Nucleotide sequences coding epidermal growth factor polypeptide for use in diagnosis, prevention and treatment of cell and metabolic disorders; pharmacogenomic; drug screening and design |
| 06/23/2005 | US20050136447 Rapid subcloning using site-specific recombination |
| 06/23/2005 | US20050136443 Using cyclic replication to propagate and recover preferential nucleotide sequences; polymerase chain reaction |
| 06/23/2005 | US20050136439 Nucleic acids comprising palladium plates and cobalt-iron oxide spheres, cubes, fibers and nanotubes |
| 06/23/2005 | US20050136437 Nanoparticles for delivery of nucleic acids and stable double-stranded RNA |
| 06/23/2005 | US20050136436 Double stranded short interfering nucleic acid for use in the treatment of schizophrenia; gene expression inhibition and hairpin loops |
| 06/23/2005 | US20050136430 Inhibitor nucleic acids |
| 06/23/2005 | US20050136428 Look-through mutagenesis |
| 06/23/2005 | US20050136409 comprising biopolymer-coated erythrocytes simulating a component of blood samples, obtained by binding biopolymers to the external surface of cells, the biopolymers comprising nucleic acids, peptide nucleic acids, or mucopolysaccharides; used in cytometer or analysis apparatus |
| 06/23/2005 | US20050136403 Molecular characterists of non-small cell lung cancer |
| 06/23/2005 | US20050136402 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |
| 06/23/2005 | US20050136400 NS3-NS4A protease resistance mutants |
| 06/23/2005 | US20050136399 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 06/23/2005 | US20050136393 Oligonucleotide primers inserted into stranded expression vectors and cell transformed with this |
| 06/23/2005 | US20050136076 Immunogenic detoxified mutants of cholera toxin |
| 06/23/2005 | US20050136071 Hsp70 from arthrobacter |
| 06/23/2005 | US20050136070 Isolation and characterization of the csa operon (ETEC-CS4 Pili) and methods of using same |
| 06/23/2005 | US20050136069 Immunogenic portion of Mycobacterium tuberculosis proteins and monophosphoryl lipid A as adjuvant; vaccines |
| 06/23/2005 | US20050136068 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus |
| 06/23/2005 | US20050136067 Multimeric hybrid gene having a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen, especially coding for a parainfluenza virus and a respiratory syncytial virus; vaccines |
| 06/23/2005 | US20050136057 Chimeric L chain comprising an L chain C region of a human antibody and an L chain V region of a mouse monoclonal antibody against a human parathyroid hormone related protein; may be used widely in hypercalcemia associated with various cancers |
| 06/23/2005 | US20050136054 Humanised antibodies |
| 06/23/2005 | US20050136053 Tie1-binding ligands |
| 06/23/2005 | US20050136045 Can be administered by continuous infusion or by single intravenous bolus injection; use in the treatment of arterial thrombosis and for treating myocardial infarction; reduced antigenicity and immunogenicity as compared to wild-type staphylokinase |
| 06/23/2005 | US20050136042 Methods and compositions for tissue repair |
| 06/23/2005 | US20050136041 Transgenic cell comprising nucleotide sequences coding erythropoietin and/or glucagon-like peptides for use in treatment and prevention of blood and metabolic disorders; somatic and germ cell gene therapy; tissue engineering |
| 06/23/2005 | US20050136040 Peptide nucleic acid of a nucleic acid binding portion and a repressor portion of a polypeptide or peptidomimetic; drug design; gene expression inhibition |
| 06/23/2005 | US20050136039 Can exhibit decreased expression of: fatty acid synthase (FAS), adipogenic transcription factors SREBP-1c or C/EBP alpha , beta 3 adrenergic receptor, and fatty acid transport protein 1 (FATP1); use drug screening; prognosis of obesity; diabetes; reduction of insulin receptor signaling |
| 06/23/2005 | US20050136036 Methods and compositions for the treatment of neurological disease |
| 06/23/2005 | US20050136035 Targeted adenovirus vectors include co-transcribed genes under transcriptional control of the same heterologous transcriptional regulatory element (TRE), wherein a second gene is under translational control of a self processing cleavage sequence or 2A sequence; cell or tissue-targeted therapy; e.g. tumor |
| 06/23/2005 | DE102004055686A1 New modified sarcosine oxidase, useful as diagnostic reagent for measuring creatinine or creatine, has reduced activity on N-ethylglycine, also nucleic acid that encodes it |
| 06/23/2005 | CA2832293A1 Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof |
| 06/23/2005 | CA2568898A1 Viral vectors controlled by a gene switch |
| 06/23/2005 | CA2549710A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them |
| 06/23/2005 | CA2549482A1 Megsin/rage/inos overexpressing renaldisease model animals and methods for evaluating compounds using the model animals |
| 06/23/2005 | CA2549384A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 06/23/2005 | CA2548950A1 Methods for enhancing antibody activity |
| 06/23/2005 | CA2548929A1 Cell death inducing agent |
| 06/23/2005 | CA2548808A1 Monoclonal antibodies that bind or neutralize dengue virus |